What does ohtuvayre inventors — gross carrying value mean?

This metric reflects the total historical cost or initial recognized value of the royalty assets associated with the Ohtuvayre product line before any adjustments for impairment or amortization. It provides insight into the total capital investment or acquisition cost allocated to this specific intellectual property. Investors use this to understand the scale of the asset base dedicated to this product segment.

Ligand Pharmaceuticals LGND Ohtuvayre inventors — Gross carrying value

Other product segments

Qarziba

$103.72M—

Similar metrics at other companies

AMEGross Carrying Amount

$5.13B+9.4%

MDLZGross Carrying Amount

$3.46B+3.0%

GDGross Carrying Amount

$3.94B+1.0%

ROKGross Carrying Amount

$1.29B-17.4%

PEPGross Carrying Amount

$3.14B+6.8%

DUKGross Carrying Amount

$296M0.0%

Other financials

Income statement

See full

Revenue$51.7M+14.1%

Operating income$17.4M+148%

Net income-$13.3M+68.6%

EPS (diluted)-$0.67+69.7%

Balance sheet

See full

Cash & equivalents$115.1M+140%

Total debt$5.1M+14.2%

Total equity$997.3M+25.4%

Total assets$1.5B+69.2%

Cash flow

See full

Operating cash flow$48.7M+291%

CapEx$228.0K+6.5%

Free cash flow$48.5M+289%

Valuation

See full

Market cap$5.51B+96.7%

Enterprise value$5.4B+95.4%

P/E35.9×—

P/S20.1×+4.6×

Profitability

See full

Gross margin91.9%—

Operating margin34.5%+23.0pp

Net margin55.9%+35.7pp

FCF margin44.8%+16.8pp

Returns & leverage

See full

Return on equity17.1%+11.5pp

Debt / equity0×0.0×

Current ratio21.3×+16.0×

Where this comes from

Reported directly by Ligand Pharmaceuticals in its filing.

Tagged under the XBRL concept lgnd:FinancialRoyaltyAssetsGross.

The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ligand Pharmaceuticals's ohtuvayre inventors — gross carrying value.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ligand Pharmaceuticals's ohtuvayre inventors — gross carrying value?: Ligand Pharmaceuticals (LGND) reported ohtuvayre inventors — gross carrying value of $18M in Q1 2026.
What does ohtuvayre inventors — gross carrying value mean?: This metric reflects the total historical cost or initial recognized value of the royalty assets associated with the Ohtuvayre product line before any adjustments for impairment or amortization. It provides insight into the total capital investment or acquisition cost allocated to this specific intellectual property. Investors use this to understand the scale of the asset base dedicated to this product segment.